𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria

✍ Scribed by H.J. Vernon; C.B. Koerner; M.R. Johnson; A. Bergner; A. Hamosh


Book ID
116988990
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
231 KB
Volume
100
Category
Article
ISSN
1096-7192

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Safety and efficacy of 22 weeks of treat
✍ Phillip Lee; Eileen P. Treacy; Eric Crombez; Melissa Wasserstein; Lewis Waber; J πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## Abstract Phenylketonuria (PKU) is an inherited metabolic disease characterized by phenylalanine (Phe) accumulation, which can lead to neurocognitive and neuromotor impairment. Sapropterin dihydrochloride, an FDA‐approved synthetic formulation of tetrahydrobiopterin (6R‐BH4, herein referred to as